- JP-listed companies
- Dividends
(130A) Dividends
Market cap
¥3.1B
P/E ratio
-5.4x
Veritas In Silico develops small-molecule drugs targeting messenger RNA using its ibVIS platform, partnering with major pharmaceutical companies like Takeda and Shionogi.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of , the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>Regarding our dividend policy, we decide based on our financial condition and business performance. Currently, as we are in a growth phase, we prioritize investing management resources into our business to enhance shareholder value in the future, and we do not pay cash dividends. We distribute surplus dividends twice a year on a regular basis, consisting of year-end and interim dividends.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2026/02/12) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2026/02/12) | 0 | 0 | 0 | - |
| Forecast(2025/02/13) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2025/02/13) | 0 | 0 | 0 | - |
| Forecast(2024/02/13) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2024/02/13) | 0 | 0 | 0 | - |
| FY2022 | Actual(2024/02/13) | 0 | 0 | 0 | - |